Issued Patents 2020
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10851358 | Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome | James Jefferson Smith | 2020-12-01 |
| 10822610 | Methods for producing a complex transgenic trait locus | Andrew Mark Cigan, Saverio Carl Falco, Huirong Gao, Michael Lassner, Zhongsen Li +3 more | 2020-11-03 |
| 10799535 | Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene | Michael G. Nicholson, James Jefferson Smith, Victor Bartsevich, Daniel T. MacLeod, Jeyaraj Antony | 2020-10-13 |
| 10800833 | Co-stimulatory domains for use in genetically-modified cells | Aaron Martin, Daniel T. MacLeod | 2020-10-13 |
| 10758595 | Treatment of retinitis pigmentosa using engineered meganucleases | Victor Bartsevich, James Jefferson Smith, Michael G. Nicholson | 2020-09-01 |
| 10745665 | Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof | Joann Hux, Aaron Martin, Clayton Beard | 2020-08-18 |
| 10662440 | Self-limiting viral vectors encoding nucleases | James Jefferson Smith, Michael G. Nicholson | 2020-05-26 |
| 10662416 | Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome | James Jefferson Smith | 2020-05-26 |
| 10603363 | Treatment of retinitis pigmentosa using engineered meganucleases | Victor Bartsevich, James Jefferson Smith, Michael G. Nicholson | 2020-03-31 |